The novel tumor suppressor IRF2BP2 regulates Hippo pathway in liver cancer via a feedback loop.
The conserved Hippo pathway regulates organ size, tissue homeostasis and tumorigenesis. IRF2BP2 was originally identified as a transcriptional co-repressor. However, the association between IRF2BP2 and Hippo pathway remains largely unknown. In addition, the biological function and the regulation mechanism of IRF2BP2 in liver cancer are poorly understood. In this study, we uncovered the clinical significance of IRF2BP2 in suppressing hepatocellular carcinogenesis. We showed that IRF2BP2, a direct target repressed by the YAP-TEAD4 transcriptional complex, inhibited YAP activity via a feedback loop. IRF2BP2 stabilized VGLL4, and further enhanced VGLL4's inhibitory function on YAP. Moreover, liver-specific IRF2BP2 overexpression suppressed tumor formation induced by Hippo pathway inactivation. These results revealed the important role of IRF2BP2 in repressing liver cancer progression, and highlighted a feedback loop underlying Hippo pathway in organ size control and tumorigenesis.